• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化的 DNA 电穿孔用于原代人 T 细胞工程。

Optimized DNA electroporation for primary human T cell engineering.

机构信息

Laboratory of Vaccine and Antibody Engineering, Beijing Institute of Biotechnology, No. 20, Dongdajie street, Fengtai District, Beijing, 100071, China.

Institute of Health Sciences, Anhui University, No. 111, Jiulong Road, Hefei, 230601, China.

出版信息

BMC Biotechnol. 2018 Jan 30;18(1):4. doi: 10.1186/s12896-018-0419-0.

DOI:10.1186/s12896-018-0419-0
PMID:29378552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5789706/
Abstract

BACKGROUND

Effective gene-delivery systems for primary human T cell engineering are useful tools for both basic research and clinical immunotherapy applications. Pseudovirus-based systems and electro-transfection are the most popular strategies for genetic material transduction. Compared with viral-particle-mediated approaches, electro-transfection is theoretically safer, because it does not promote transgene integration into the host genome. Additionally, the simplicity and speed of the procedure increases the attractiveness of electroporation. Here, we developed and optimized an electro-transfection method for the production of engineered chimeric antigen receptor (CAR)-T cells.

RESULTS

Stimulation of T cells had the greatest effect on their transfection, with stimulation of cells for up to 3 days substantially improving transfection efficiency. Additionally, the strength of the external electric field, input cell number, and the initial amount of DNA significantly affected transfection performance. The voltage applied during electroporation affected plasmid permeation and was negatively correlated with the number of viable cells after electroporation. Moreover, higher plasmid concentration increased the proportion of positively transfected cells, but decreased cell viability, and for single-activated cells, higher cell density enhanced their viability. We evaluated the effects of two clinically relevant factors, serum supplementation in the culture medium and cryopreservation immediately after the isolation of peripheral blood lymphocytes. Our findings showed that our protocol performed well using xeno-free cultured, fresh T cells, with application resulting in a lower but acceptable transfection efficiency of cells cultured with fetal bovine serum or thawed cells. Furthermore, we described an optimized procedure to generate CAR-T cells within 6 days and that exhibited cytotoxicity toward targeted cells.

CONCLUSIONS

Our investigation of DNA electro-transfection for the use in human primary T cell engineering established and validated an optimized method for the construction of functional CAR-T cells.

摘要

背景

有效的原发性人 T 细胞工程基因传递系统是基础研究和临床免疫治疗应用的有用工具。假病毒为基础的系统和电转染是遗传物质转导的最流行策略。与病毒颗粒介导的方法相比,电转染在理论上更安全,因为它不会促进转基因整合到宿主基因组中。此外,该过程的简单性和速度增加了电穿孔的吸引力。在这里,我们开发并优化了用于生产工程嵌合抗原受体(CAR)-T 细胞的电转染方法。

结果

T 细胞的刺激对其转染效果最大,刺激细胞长达 3 天可显著提高转染效率。此外,外部电场强度、输入细胞数量和初始 DNA 量对转染性能有显著影响。电穿孔过程中施加的电压会影响质粒渗透,与电穿孔后存活细胞的数量呈负相关。此外,更高的质粒浓度会增加阳性转染细胞的比例,但会降低细胞活力,对于单个激活的细胞,更高的细胞密度会提高其活力。我们评估了两种临床相关因素的影响,即培养基中血清补充和外周血淋巴细胞分离后立即冷冻保存。我们的研究结果表明,我们的方案在使用无动物源培养的新鲜 T 细胞时表现良好,应用该方案可降低但可接受地转染培养有胎牛血清或解冻细胞的细胞的转染效率。此外,我们描述了一种优化的程序,可在 6 天内生成具有靶向细胞毒性的 CAR-T 细胞。

结论

我们对 DNA 电转染在人原发性 T 细胞工程中的应用进行了研究,建立并验证了一种优化的方法,用于构建功能性 CAR-T 细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1362/5789706/0e3d10435ea8/12896_2018_419_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1362/5789706/8795c46edc3d/12896_2018_419_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1362/5789706/07f11397aa61/12896_2018_419_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1362/5789706/016b3da01af6/12896_2018_419_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1362/5789706/0b46a5fc16dc/12896_2018_419_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1362/5789706/0e3d10435ea8/12896_2018_419_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1362/5789706/8795c46edc3d/12896_2018_419_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1362/5789706/07f11397aa61/12896_2018_419_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1362/5789706/016b3da01af6/12896_2018_419_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1362/5789706/0b46a5fc16dc/12896_2018_419_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1362/5789706/0e3d10435ea8/12896_2018_419_Fig5_HTML.jpg

相似文献

1
Optimized DNA electroporation for primary human T cell engineering.优化的 DNA 电穿孔用于原代人 T 细胞工程。
BMC Biotechnol. 2018 Jan 30;18(1):4. doi: 10.1186/s12896-018-0419-0.
2
High-level transgene expression in primary human T lymphocytes and adult bone marrow CD34+ cells via electroporation-mediated gene delivery.通过电穿孔介导的基因递送在原代人T淋巴细胞和成人骨髓CD34+细胞中实现高水平转基因表达。
Gene Ther. 2000 Aug;7(16):1431-7. doi: 10.1038/sj.gt.3301252.
3
Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation.通过在成熟后而非成熟前转染特定RNA来生成优化的多价单核细胞衍生树突状细胞疫苗。
J Immunol. 2005 Mar 1;174(5):3087-97. doi: 10.4049/jimmunol.174.5.3087.
4
A new approach to CAR T-cell gene engineering and cultivation using piggyBac transposon in the presence of IL-4, IL-7 and IL-21.一种新的方法,使用 piggyBac 转座子在 IL-4、IL-7 和 IL-21 的存在下进行 CAR T 细胞基因工程和培养。
Cytotherapy. 2018 Apr;20(4):507-520. doi: 10.1016/j.jcyt.2017.10.001. Epub 2018 Feb 21.
5
Nucleofection with Plasmid DNA for CRISPR/Cas9-Mediated Inactivation of Programmed Cell Death Protein 1 in CD133-Specific CAR T Cells.用质粒 DNA 进行核转染以实现 CRISPR/Cas9 介导的 CD133 特异性嵌合抗原受体 T 细胞中程序性细胞死亡蛋白 1 的失活
Hum Gene Ther. 2019 Apr;30(4):446-458. doi: 10.1089/hum.2017.234. Epub 2018 Apr 27.
6
Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cells.通过静息步骤提高临床级嵌合抗原受体工程化 T 细胞的体外效力测定。
Cytotherapy. 2019 May;21(5):566-578. doi: 10.1016/j.jcyt.2019.02.013. Epub 2019 Mar 23.
7
Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors.自然杀伤细胞亚群的内在功能潜能限制了嵌合抗原受体驱动的重定向。
Cancer Immunol Res. 2018 Apr;6(4):467-480. doi: 10.1158/2326-6066.CIR-17-0207. Epub 2018 Feb 19.
8
Differences in the phenotypes and transcriptomic signatures of chimeric antigen receptor T lymphocytes manufactured electroporation or lentiviral transfection.电穿孔或慢病毒转染制造的嵌合抗原受体 T 淋巴细胞的表型和转录组特征的差异。
Front Immunol. 2023 May 9;14:1068625. doi: 10.3389/fimmu.2023.1068625. eCollection 2023.
9
Ex vivo electroporation of retinal cells: a novel, high efficiency method for functional studies in primary retinal cultures.视网膜细胞的体外电穿孔:一种用于原代视网膜培养物功能研究的新型、高效方法。
Exp Eye Res. 2013 Apr;109:40-50. doi: 10.1016/j.exer.2013.01.010. Epub 2013 Jan 28.
10
Clinical application of Sleeping Beauty and artificial antigen presenting cells to genetically modify T cells from peripheral and umbilical cord blood.睡美人转座子系统及人工抗原呈递细胞在对来自外周血和脐带血的T细胞进行基因改造中的临床应用
J Vis Exp. 2013 Feb 1(72):e50070. doi: 10.3791/50070.

引用本文的文献

1
Miniaturized scalable arrayed CRISPR screening in primary cells enables discovery at the single donor resolution.原代细胞中的小型化可扩展阵列CRISPR筛选能够在单供体分辨率下进行发现。
Sci Rep. 2025 Aug 11;15(1):29350. doi: 10.1038/s41598-025-13532-z.
2
Applying CRISPR Technologies for the Treatment of Human Herpesvirus Infections: A Scoping Review.应用CRISPR技术治疗人类疱疹病毒感染:一项范围综述。
Pathogens. 2025 Jul 1;14(7):654. doi: 10.3390/pathogens14070654.
3
Enhancing Chimeric Antigen Receptor T-Cell Generation via Microfluidic Mechanoporation and Lipid Nanoparticles.

本文引用的文献

1
Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition.多重基因组编辑以产生对PD1抑制具有抗性的通用嵌合抗原受体T细胞
Clin Cancer Res. 2017 May 1;23(9):2255-2266. doi: 10.1158/1078-0432.CCR-16-1300. Epub 2016 Nov 4.
2
Engineered T cells: the promise and challenges of cancer immunotherapy.工程化T细胞:癌症免疫疗法的前景与挑战
Nat Rev Cancer. 2016 Aug 23;16(9):566-81. doi: 10.1038/nrc.2016.97.
3
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.使用睡美人转座子系统生成CD19特异性嵌合抗原受体T细胞的I期试验。
通过微流控机械穿孔和脂质纳米颗粒增强嵌合抗原受体T细胞的生成
Small. 2025 Apr;21(17):e2410975. doi: 10.1002/smll.202410975. Epub 2025 Mar 19.
4
Enhancement effect of urea toward electroporation-mediated plasmid transfection efficiency in the HEK-293 cell line.尿素对人胚肾细胞系(HEK-293)中电穿孔介导的质粒转染效率的增强作用。
Res Pharm Sci. 2024 Dec 15;19(6):766-773. doi: 10.4103/RPS.RPS_185_23. eCollection 2024 Dec.
5
Photothermal nanofiber-mediated photoporation for gentle and efficient intracellular delivery of macromolecules.光热纳米纤维介导的光穿孔用于大分子的温和高效细胞内递送。
Nat Protoc. 2025 Jan 22. doi: 10.1038/s41596-024-01115-7.
6
A structural, genetic and clinical comparison of CAR-T cells and CAR-NK cells: companions or competitors?CAR-T 细胞与 CAR-NK 细胞的结构、遗传和临床比较:是伙伴还是竞争对手?
Front Immunol. 2024 Oct 4;15:1459818. doi: 10.3389/fimmu.2024.1459818. eCollection 2024.
7
Exploring non-viral methods for the delivery of CRISPR-Cas ribonucleoprotein to hematopoietic stem cells.探索非病毒方法将 CRISPR-Cas 核糖核蛋白递送至造血干细胞。
Stem Cell Res Ther. 2024 Jul 29;15(1):233. doi: 10.1186/s13287-024-03848-4.
8
Functionalized nanowires for miRNA-mediated therapeutic programming of naïve T cells.功能化纳米线用于 miRNA 介导的幼稚 T 细胞治疗编程。
Nat Nanotechnol. 2024 Aug;19(8):1190-1202. doi: 10.1038/s41565-024-01649-7. Epub 2024 Apr 29.
9
The Progress and Prospects of Immune Cell Therapy for the Treatment of Cancer.免疫细胞疗法治疗癌症的进展与前景
Cell Transplant. 2024 Jan-Dec;33:9636897241231892. doi: 10.1177/09636897241231892.
10
Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repair.通过同源介导的末端连接DNA修复,Cas9诱导大DNA有效载荷在原代人T细胞中的靶向整合。
Nat Biomed Eng. 2024 Dec;8(12):1553-1570. doi: 10.1038/s41551-023-01157-4. Epub 2023 Dec 13.
J Clin Invest. 2016 Sep 1;126(9):3363-76. doi: 10.1172/JCI86721. Epub 2016 Aug 2.
4
Early memory phenotypes drive T cell proliferation in patients with pediatric malignancies.早期记忆表型驱动儿科恶性肿瘤患者 T 细胞增殖。
Sci Transl Med. 2016 Jan 6;8(320):320ra3. doi: 10.1126/scitranslmed.aad5222.
5
Regulatory T cell memory.调节性T细胞记忆
Nat Rev Immunol. 2016 Feb;16(2):90-101. doi: 10.1038/nri.2015.1. Epub 2015 Dec 21.
6
T cell engineering as therapy for cancer and HIV: our synthetic future.作为癌症和艾滋病治疗手段的T细胞工程:我们的合成未来。
Philos Trans R Soc Lond B Biol Sci. 2015 Oct 19;370(1680):20140374. doi: 10.1098/rstb.2014.0374.
7
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo.源自特定CD8+和CD4+亚群的嵌合抗原受体修饰的T细胞在体内具有更强的抗肿瘤反应性。
Leukemia. 2016 Feb;30(2):492-500. doi: 10.1038/leu.2015.247. Epub 2015 Sep 15.
8
Performance-enhancing drugs: design and production of redirected chimeric antigen receptor (CAR) T cells.增强性能的药物:重定向嵌合抗原受体 (CAR) T 细胞的设计和生产。
Cancer Gene Ther. 2015 Mar;22(2):79-84. doi: 10.1038/cgt.2015.5. Epub 2015 Feb 13.
9
Ex vivo expansion of human T cells for adoptive immunotherapy using the novel Xeno-free CTS Immune Cell Serum Replacement.使用新型无动物源 CTS 免疫细胞血清替代物进行人 T 细胞过继免疫治疗的体外扩增。
Clin Transl Immunology. 2015 Jan 16;4(1):e31. doi: 10.1038/cti.2014.31. eCollection 2015 Jan.
10
Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells.鉴定介导 T 细胞组成性或诱导性增殖的嵌合抗原受体。
Cancer Immunol Res. 2015 Apr;3(4):356-67. doi: 10.1158/2326-6066.CIR-14-0186. Epub 2015 Jan 19.